UCSF Scientists, Leaders Highlight Latest Advances at 2017 Precision Medicine World Conference

UCSF Scientists, Leaders Highlight Latest Advances at 2017 Precision Medicine World Conference

March 1, 2017

Scientists, clinicians and entrepreneurs shared the latest innovations and initiatives in the rapidly evolving movement to make health care more personal, predictive and preventive at the Precision Medicine World Conference (PMWC) in January.

Genetic 'Balance' May Influence Response to Cancer Treatment

Genetic 'Balance' May Influence Response to Cancer Treatment

February 27, 2017

Choosing among cancer treatments increasingly involves determining whether tumor cells harbor specific, mutated “oncogenes” that drive abnormal growth and that may also be especially vulnerable or resistant to particular drugs. But according to a new study led by UCSF researchers, in the case of the ...
Exploring Genomics' Gray Zone to Improve Cancer Treatment Options

Exploring Genomics' Gray Zone to Improve Cancer Treatment Options

February 15, 2017

Last year, UCSF launched the Molecular Oncology Initiative (MOI) to integrate molecular information found in most cancer types with the ever increasing number of therapeutics being developed in translational research and clinical practice.   The UCSF Molecular Tumor Board (MTB), a group of experts ...
Scalp Cooling Can Help Some Breast Cancer Patients Retain Hair

Scalp Cooling Can Help Some Breast Cancer Patients Retain Hair

February 14, 2017

Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers.

15 UCSF Researchers Named to First Cohort of Chan Zuckerberg Biohub Investigators

15 UCSF Researchers Named to First Cohort of Chan Zuckerberg Biohub Investigators

February 7, 2017

Fifteen UC San Francisco faculty members have been named to the first cohort of Chan Zuckerberg Biohub Investigators.

Precision-Medicine Approach Could Revive Prostate Cancer Test

Precision-Medicine Approach Could Revive Prostate Cancer Test

February 2, 2017

A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.